NurrOn Pharmaceuticals welcomes Dr. Almira Chabi to its Board of Directors

– SOUTH KOREA, Seoul –  NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson’s disease and other Nurr1-related human disorders, today announced the appointment of Dr.

Hugel appoins Suk-yong Cha to its Board of Directors as Executive Chairman

– SOUTH KOREA, Seoul –  Hugel Inc. (KOSDAQ: 145020), a global total medical aesthetics company, today announced the appointment of Suk-yong Cha to its Board as Executive Chairman effective on March 30th, succeeding Brent Saunders who become Chair of a newly established Advisory Board.…

Orum Therapeutics welcomes David Main to its Board of Directors

– SOUTH KOREA, Daejeon / USA, MA –  Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders to treat cancer, today announced the appointment of David Main to its Board of Directors.…